Virnich Daniel 4

What Happened Daniel Virnich, CEO of Oncology Institute, Inc. (TOI), disposed of 23,058 shares on May 21, 2026. The shares were sold at $4.47 per share for a total proceeds of $103,069. The transaction is reported as an "other acquisition or disposition (J)" but the filing’s footnote states the sale was executed by the issuer to cover tax liabilities from an RSU award vesting.

Key Details

• Transaction date and price: May 21, 2026 — 23,058 shares at $4.47 each (total $103,069).
• Reported as: Other acquisition/disposition (Code J); footnote F1 explains sale to satisfy tax withholding on RSU vesting.
• Vesting origin: RSU award made May 21, 2024 (per footnote).
• Filing date: May 22, 2026 (appears timely; Form 4s must generally be filed within two business days).
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context This was a sale executed to cover tax obligations tied to RSU vesting (a cashless withholding-style transaction), which is a routine administrative transaction and not necessarily an indicator of the CEO’s view on the company’s prospects. Purchases tend to be more informative about insider sentiment; tax-related sales are common following equity awards.